Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Maravai Lifesciences Holdings Inc Cl A (NQ: MRVI )

8.110 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 8.110
Bid (Size) 3.470 (1)
Ask (Size) 8.480 (1)
Prev. Close 8.110
Today's Range 8.110 - 8.110
52wk Range 4.520 - 15.08
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were lower, with the Dow Jones index falling over 200 points on Tuesday. Shares of BlackBerry Limited (NYSE: BB) rose sharply during Tuesday’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities

Performance

YTD
+20.33%
+20.33%
1 Month
+1.88%
+1.88%
3 Month
+26.13%
+26.13%
6 Month
+7.56%
+7.56%
1 Year
-42.64%
-42.64%

More News

Read More
Dyadic International Inc. (NASDAQ: DYAI) Funding to Propel Near-Term Revenue Growth Initiatives Highlights in Zacks Small-Cap Research Report
Via AB Newswire
Topics Regulatory Compliance
Exposures Legal Regulatory
Recap: Maravai LifeSciences Q4 Earnings
Via Benzinga
Maravai LifeSciences Announces March 2024 Investor Conference Schedule
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Market Momentum: NASDAQ SmallCaps Sparking Waves in March 2024: CELZ, DYAI, GROM, VTAK, BREA
Via AB Newswire
Exposures Product Safety
Recent Market Movers: Healthcare Companies Making Headlines: DYAI, RIGL, ARDX, VERO, MEDS
Via AB Newswire
Healthcare Undervalued Opportunities Poised for Growth: DYAI, INBS, VTAK, RSCI, VERO, MRVI
Via AB Newswire
Nasdaq Edges Lower; AXT Shares Surge After Q4 Results
Via Benzinga
Topics Stocks
Exposures US Equities
Small-Cap Maravai LifeSciences' Q4 Outperforms Expectations, Analyst shows Optimism Around 2024 Guidance
Via Benzinga
Why MercadoLibre Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Crude Oil Down 2%; Maravai LifeSciences Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Carvana Posts Q4 Results, Joins LegalZoom.com, Comfort Systems And Other Big Stocks Moving Higher On Friday
Via Benzinga
Topics Stocks
Exposures US Equities
Dow Surges Over 150 Points; AerCap Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Why AXT Shares Are Trading Higher By Around 36%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Nasdaq, S&P 500 Set for Mixed Open After Nvidia Euphoria: Analyst Picks Major Market Catalyst This Year If There Are No Rate Cuts
Via Benzinga
Topics Stocks
Exposures US Equities
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Maravai LifeSciences (MRVI) Q4 2023 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
TriLink BioTechnologies® Solidifies IP Position with Awarded Patents for CleanCap® Capping Technology in China and Canada
From TriLink BioTechnologies
Via Business Wire
Earnings Scheduled For February 22, 2024
Via Benzinga
Nasdaq Stocks Are Taking Center Stage This Week! DYAI, MRVI, SPWR, VTAK, KAVL, INBS
Via AB Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.